BD announces first pharma-sponsored clinical trial using BD Libertas wearable injector technology for biologic drugs Read more
Amylyx’s efforts to explore other indications for Relyvrio seems to be bearing fruit: GlobalData Read more
Puma Biotechnology announces presentation of findings from a phase II study of alisertib in endocrine-resistant metastatic breast cancer Read more
PROSEEK study shows no treatment benefit of Vodobatinib in patients with early Parkinson’s Disease Read more
Suven announces randomisation of first patient in Phase-2 POC clinical trial of Ropanicant (SUVN-911) Read more
Verve’s gene-editing therapy trial to lower cholesterol levels opens doors for use in CVDs: GlobalData Read more
SPARC completes enrolment in PROSEEK, Phase 2 study of Vodobatinib in early Parkinson’s disease Read more